← All reportsView on Symbol
KRYS

KRYS

High conviction

Krystal Biotech, Inc.

Healthcare · NASDAQ

$9.9B mkt cap

Brief updated Jul 26, 2026

Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for

Decifer Research·Data summary

KRYS is a high-conviction name in Healthcare

KRYS sits at the intersection of key themes currently active in the market. The scoring engine rates it high based on how well the active market forces line up with its business, plus available fundamental data. Financial metrics and analyst consensus provide additional context.

Why now

The market forces active right now are aligned with the company's core business exposure. The timing reflects the intersection of theme strength and available catalyst data.

Key risks

Data availability limits full scoring across all dimensions. Market forces can reverse rapidly; theme exposure does not guarantee the price follows. Fundamental valuation data may not reflect the most recent quarterly results.

What to watch

Monitor conviction score changes, especially the macro and analyst dimensions. Earnings guidance updates and analyst consensus shifts are the primary near-term catalysts.

52High conviction Conviction
macro
5/25
analyst
15/38
momentum
13/20
forward catalyst
0/15
valuation
18/23
highs
3/12
news catalyst
-3/12
options flow
10/12
peer network
0/8
counter thesis
0/3
Key financials
Revenue growth (YoY)864.0%
Gross margin9279.0%
Operating margin4285.0%
Net margin5392.0%
P/E ratio43.6x
Return on equity1925.0%
FCF yield240.0%
Debt / equity0.0x
EV / sales22.5x
Valuation
Analyst consensusBUY
DCF fair value$540
Next EPS estimate$1.94
Macro context

Nasdaq, S&P 500, Dow Futures Fall After Trump Directs Strikes ‘To Hold Iranian Forces Accountable’: NVDA, SLS, MRK, SKHYV, QS Stocks In Focus

The US has launched strikes against Iranian forces, prompting a risk-off sentiment in the markets, with major indexes like Nasdaq, S&P 500, and Dow Futures experiencing declines. This escalation in military conflict could lead to further geopolitical tensions and market volatility.

Jul 13, 2026

Nasdaq, S&P 500 Futures Slip As Iran Tensions Rattle Markets Again: Why MU, TSLA, BATL, SKHYV, MSFT, TSM, SLS Are In Focus

Rising tensions with Iran are causing market jitters, leading to a decline in Nasdaq and S&P 500 futures, as investors become increasingly risk-averse. This escalation has the potential to impact global markets and asset classes.

Jul 13, 2026

Stock Market Today: Dow Futures Gain, S&P 500 Slips as US and Iran Exchange Strikes—Saratoga, Exxon Mobil, Levi Strauss in Focus

The US and Iran have exchanged strikes, escalating geopolitical tensions and potentially impacting global markets. This development could lead to increased uncertainty and volatility in various asset classes.

Jul 13, 2026

Stock Market Today: Nasdaq Slides On New U.S.-Iran Strikes; SK Hynix Plunges (Live Coverage)

The US has launched new strikes against Iran, escalating tensions and causing market volatility, with the Nasdaq sliding in response. This development has significant implications for global geopolitics and market risk appetite.

Jul 13, 2026

Analyst intelligence
17 Buy0 Hold0 Sell
Earnings intelligence

Earnings surprises

+26.2%

2026-05

+4.9%

2026-02

+137.5%

2025-11

+19.4%

2025-08

-13.0%

2025-05

Recent updates
other macro4d ago

TSMC stock drops 4.1% amid a $2 trillion AI rout, indicating a potential shift in investor sentiment towards AI-related stocks and the broader tech sector. This event may have implications for the tech industry and the global economy.

geopolitical escalation4d ago

The US equity indexes are sliding ahead of Fed Governor Warsh's press briefing and big-tech results, as President Trump vows to hit Iran hard, escalating geopolitical tensions. This escalation could lead to increased market volatility and risk aversion.

central bank rate decision4d ago

The equities market is experiencing intraday losses ahead of the highly anticipated Federal Reserve decision, which could significantly impact market direction and investor sentiment. The decision, coupled with major tech earnings reports, is poised to influence the overall economic outlook.

natural disaster5d ago

TSMC's Japan semiconductor fabrication plant is gradually resuming operations following an earthquake-induced disruption. This matters because TSMC is a critical node in the global semiconductor supply chain, and even partial outages can ripple through electronics and chip-dependent industries.

oil supply shock5d ago

US Strategic Petroleum Reserve levels have fallen to a 43-year low, reducing the government's capacity to buffer oil price shocks at a time of active Middle East conflict. This structural vulnerability in US energy policy raises concerns about energy security and the ability to respond to supply disruptions.

Generated Sun, 26 Jul 2026 06:06:19 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.